# FDA Inspection 1165829 - Lipika Goyal, M.D. - March 18, 2022

Source: https://www.keypedia.com/records/fda_inspections/lipika-goyal-md/baa5d186-39fa-49f1-92cf-dc879123007a
Source feed: FDA_Inspections

> FDA Inspection 1165829 for Lipika Goyal, M.D. on March 18, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1165829
- Company Name: Lipika Goyal, M.D.
- Inspection Date: 2022-03-18
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/lipika-goyal-md/a0efa1d2-7509-4a6b-91c6-1c1434d0995e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c